Time-dependent diaryl ether inhibitors of InhA: Structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy

Pan Pan, Susan E. Knudson, Gopal R. Bommineni, Huei Jiun Li, Cheng Tsung Lai, Nina Liu, Miguel Garcia-Diaz, Carlos Simmerling, Sachindra S. Patil, Richard A. Slayden, Peter J. Tonge

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The diaryl ethers are a novel class of antituberculosis drug candidates that inhibit InhA, the enoyl-ACP reductase involved in the fatty acid biosynthesis (FASII) pathway, and have antibacterial activity against both drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis. In the present work, we demonstrate that two time-dependent B-ring modified diaryl ether InhA inhibitors have antibacterial activity in a mouse model of TB infection when delivered by intraperitoneal injection. We propose that the efficacy of these compounds is related to their residence time on the enzyme, and to identify structural features that modulate drug-target residence time in this system, we have explored the inhibition of InhA by a series of B-ring modified analogues. Seven ortho-substituted compounds were found to be time-dependent inhibitors of InhA, where the slow step leading to the final enzyme-inhibitor complex (EI*) is thought to correlate with closure and ordering of the InhA substrate binding loop. A detailed mechanistic understanding of the molecular basis for residence time in this system will facilitate the development of InhA inhibitors with improved in vivo activity. No turning back: A series of diaryl ethers was designed with modifications to the B-ring. Structure-activity relationship studies shed light on the mechanism of time-dependent inhibition of InhA: during inhibitor binding, a slow step that leads to the final enzyme-inhibitor complex (EI*) is thought to correlate with closure and ordering of the substrate binding loop. In a mouse model of tuberculosis infection, two of the time-dependent InhA inhibitors synthesized decreased the antibacterial load by 0.5-0.7 log units.

Original languageEnglish (US)
Pages (from-to)776-791
Number of pages16
JournalChemMedChem
Volume9
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Enzyme inhibition
Structure-Activity Relationship
Ether
Ethers
Enzyme Inhibitors
Enzymes
Pharmaceutical Preparations
Biosynthesis
Substrates
Oxidoreductases
Fatty Acids
Infection
Intraperitoneal Injections
Mycobacterium tuberculosis
Tuberculosis

Keywords

  • diaryl ethers
  • enoyl-ACP reductases
  • fatty acid biosynthesis
  • InhA
  • inhibitors
  • structure-activity relationships
  • time-dependent inhibition

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry
  • Molecular Medicine
  • Medicine(all)

Cite this

Time-dependent diaryl ether inhibitors of InhA : Structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy. / Pan, Pan; Knudson, Susan E.; Bommineni, Gopal R.; Li, Huei Jiun; Lai, Cheng Tsung; Liu, Nina; Garcia-Diaz, Miguel; Simmerling, Carlos; Patil, Sachindra S.; Slayden, Richard A.; Tonge, Peter J.

In: ChemMedChem, Vol. 9, No. 4, 2014, p. 776-791.

Research output: Contribution to journalArticle

Pan, P, Knudson, SE, Bommineni, GR, Li, HJ, Lai, CT, Liu, N, Garcia-Diaz, M, Simmerling, C, Patil, SS, Slayden, RA & Tonge, PJ 2014, 'Time-dependent diaryl ether inhibitors of InhA: Structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy', ChemMedChem, vol. 9, no. 4, pp. 776-791. https://doi.org/10.1002/cmdc.201300429
Pan, Pan ; Knudson, Susan E. ; Bommineni, Gopal R. ; Li, Huei Jiun ; Lai, Cheng Tsung ; Liu, Nina ; Garcia-Diaz, Miguel ; Simmerling, Carlos ; Patil, Sachindra S. ; Slayden, Richard A. ; Tonge, Peter J. / Time-dependent diaryl ether inhibitors of InhA : Structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy. In: ChemMedChem. 2014 ; Vol. 9, No. 4. pp. 776-791.
@article{f3bdb841fd43426497d5a36bbca85052,
title = "Time-dependent diaryl ether inhibitors of InhA: Structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy",
abstract = "The diaryl ethers are a novel class of antituberculosis drug candidates that inhibit InhA, the enoyl-ACP reductase involved in the fatty acid biosynthesis (FASII) pathway, and have antibacterial activity against both drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis. In the present work, we demonstrate that two time-dependent B-ring modified diaryl ether InhA inhibitors have antibacterial activity in a mouse model of TB infection when delivered by intraperitoneal injection. We propose that the efficacy of these compounds is related to their residence time on the enzyme, and to identify structural features that modulate drug-target residence time in this system, we have explored the inhibition of InhA by a series of B-ring modified analogues. Seven ortho-substituted compounds were found to be time-dependent inhibitors of InhA, where the slow step leading to the final enzyme-inhibitor complex (EI*) is thought to correlate with closure and ordering of the InhA substrate binding loop. A detailed mechanistic understanding of the molecular basis for residence time in this system will facilitate the development of InhA inhibitors with improved in vivo activity. No turning back: A series of diaryl ethers was designed with modifications to the B-ring. Structure-activity relationship studies shed light on the mechanism of time-dependent inhibition of InhA: during inhibitor binding, a slow step that leads to the final enzyme-inhibitor complex (EI*) is thought to correlate with closure and ordering of the substrate binding loop. In a mouse model of tuberculosis infection, two of the time-dependent InhA inhibitors synthesized decreased the antibacterial load by 0.5-0.7 log units.",
keywords = "diaryl ethers, enoyl-ACP reductases, fatty acid biosynthesis, InhA, inhibitors, structure-activity relationships, time-dependent inhibition",
author = "Pan Pan and Knudson, {Susan E.} and Bommineni, {Gopal R.} and Li, {Huei Jiun} and Lai, {Cheng Tsung} and Nina Liu and Miguel Garcia-Diaz and Carlos Simmerling and Patil, {Sachindra S.} and Slayden, {Richard A.} and Tonge, {Peter J.}",
year = "2014",
doi = "10.1002/cmdc.201300429",
language = "English (US)",
volume = "9",
pages = "776--791",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Time-dependent diaryl ether inhibitors of InhA

T2 - Structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy

AU - Pan, Pan

AU - Knudson, Susan E.

AU - Bommineni, Gopal R.

AU - Li, Huei Jiun

AU - Lai, Cheng Tsung

AU - Liu, Nina

AU - Garcia-Diaz, Miguel

AU - Simmerling, Carlos

AU - Patil, Sachindra S.

AU - Slayden, Richard A.

AU - Tonge, Peter J.

PY - 2014

Y1 - 2014

N2 - The diaryl ethers are a novel class of antituberculosis drug candidates that inhibit InhA, the enoyl-ACP reductase involved in the fatty acid biosynthesis (FASII) pathway, and have antibacterial activity against both drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis. In the present work, we demonstrate that two time-dependent B-ring modified diaryl ether InhA inhibitors have antibacterial activity in a mouse model of TB infection when delivered by intraperitoneal injection. We propose that the efficacy of these compounds is related to their residence time on the enzyme, and to identify structural features that modulate drug-target residence time in this system, we have explored the inhibition of InhA by a series of B-ring modified analogues. Seven ortho-substituted compounds were found to be time-dependent inhibitors of InhA, where the slow step leading to the final enzyme-inhibitor complex (EI*) is thought to correlate with closure and ordering of the InhA substrate binding loop. A detailed mechanistic understanding of the molecular basis for residence time in this system will facilitate the development of InhA inhibitors with improved in vivo activity. No turning back: A series of diaryl ethers was designed with modifications to the B-ring. Structure-activity relationship studies shed light on the mechanism of time-dependent inhibition of InhA: during inhibitor binding, a slow step that leads to the final enzyme-inhibitor complex (EI*) is thought to correlate with closure and ordering of the substrate binding loop. In a mouse model of tuberculosis infection, two of the time-dependent InhA inhibitors synthesized decreased the antibacterial load by 0.5-0.7 log units.

AB - The diaryl ethers are a novel class of antituberculosis drug candidates that inhibit InhA, the enoyl-ACP reductase involved in the fatty acid biosynthesis (FASII) pathway, and have antibacterial activity against both drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis. In the present work, we demonstrate that two time-dependent B-ring modified diaryl ether InhA inhibitors have antibacterial activity in a mouse model of TB infection when delivered by intraperitoneal injection. We propose that the efficacy of these compounds is related to their residence time on the enzyme, and to identify structural features that modulate drug-target residence time in this system, we have explored the inhibition of InhA by a series of B-ring modified analogues. Seven ortho-substituted compounds were found to be time-dependent inhibitors of InhA, where the slow step leading to the final enzyme-inhibitor complex (EI*) is thought to correlate with closure and ordering of the InhA substrate binding loop. A detailed mechanistic understanding of the molecular basis for residence time in this system will facilitate the development of InhA inhibitors with improved in vivo activity. No turning back: A series of diaryl ethers was designed with modifications to the B-ring. Structure-activity relationship studies shed light on the mechanism of time-dependent inhibition of InhA: during inhibitor binding, a slow step that leads to the final enzyme-inhibitor complex (EI*) is thought to correlate with closure and ordering of the substrate binding loop. In a mouse model of tuberculosis infection, two of the time-dependent InhA inhibitors synthesized decreased the antibacterial load by 0.5-0.7 log units.

KW - diaryl ethers

KW - enoyl-ACP reductases

KW - fatty acid biosynthesis

KW - InhA

KW - inhibitors

KW - structure-activity relationships

KW - time-dependent inhibition

UR - http://www.scopus.com/inward/record.url?scp=84898011360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898011360&partnerID=8YFLogxK

U2 - 10.1002/cmdc.201300429

DO - 10.1002/cmdc.201300429

M3 - Article

C2 - 24616444

AN - SCOPUS:84898011360

VL - 9

SP - 776

EP - 791

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 4

ER -